American International Group, Inc. Idera Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$2.37 - $3.97 $28,845 - $48,318	-12,171 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$2.33 - $3.79 $920 - $1,497	-395 Reduced 3.14%	12,171 $31,000
Q4 2018 Feb 13, 2019	SELL	$2.77 - $9.38 $265 - $900	-96 Reduced 0.76%	12,566 $35,000
Q3 2018 Nov 09, 2018	BUY	$5.53 - $11.36 $70,020 - $143,840	12,662 New	12,662 $113,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.